An updated IDI-MRSA assay version was released to address the assay's low positive
predictive value (PPV). A prospective analysis of two assay versions indicated no significant …

The IDI-MRSA assay has a sensitivity of 96% and a specificity of 96% when used to screen
patients at extranasal sites. This verification study used previously unverified swabs and was …

ABSTRACT The IDI-MRSA assay (Infectio Diagnostic, Inc., Sainte-Foy, Quebec, Canada)
with the Smart Cycler II rapid DNA amplification system (Cepheid, Sunnyvale, CA) appears …

Rapid detection of methicillin-resistant Staphylococcus aureus (MRSA) by PCR can be
performed directly from nasal specimens with the IDI-MRSA assay. To improve the efficiency …

Screening of patients is an important component for methicillin-resistant Staphylococcus
aureus (MRSA) containment. The aim of this study was to determine the utility of molecular …

Methicillin-resistant Staphylococcus aureus (MRSA) is an increasing problem. Rapid
detection of MRSA-colonized patients has the potential to limit spread of the organism. We …

We compared the BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) real-
time PCR assay with the CHROMagar MRSA assay for the detection of MRSA in 286 nasal …

We evaluated the use of the BD GeneOhm MRSA real-time PCR assay (BD Diagnostics,
San Diego, CA) for the detection of nasal colonization with methicillin-resistant …

A commercial rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus
(MRSA) screening method (IDI-MRSA) is validated for the use with nasal swabs transported …

Screening for colonization with methicillin-resistant Staphylococcus aureus (MRSA) is a key
aspect of infection control to limit the nosocomial spread of this organism. Current methods …